Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
SurVac Logo
SurVac Growth Score
80
CB Rank
3402920
Heat Score
50
SurVac is focuses on the development of peptide based therapeutic cancer vaccines.
Acquired by
Merck Logo
Merck
Founded
obfuscation
Private Hellerup, Hovedstaden, Denmark
Biotechnology
Pharmaceutical